Published in:
01-03-2017 | Original Article
T wave amplitude in lead aVR as a novel diagnostic marker for cardiac sarcoidosis
Authors:
Yoshihiro Tanaka, Tetsuo Konno, Shohei Yoshida, Toyonobu Tsuda, Kenji Sakata, Hiroshi Furusho, Masayuki Takamura, Kenichi Yoshimura, Masakazu Yamagishi, Kenshi Hayashi
Published in:
Heart and Vessels
|
Issue 3/2017
Login to get access
Abstract
It is vital to identify cardiac involvement (CI) in patients with sarcoidosis as the condition could initially lead to sudden cardiac death. Although the T wave amplitude in lead aVR (TWAaVR) is reportedly associated with adverse cardiac events in various cardiovascular diseases, only scarce data are available concerning the utility of lead aVR in identifying CI in patients with sarcoidosis. We retrospectively investigated the diagnostic values of TWAaVR in patients with sarcoidosis in comparison with conventional electrocardiography parameters such as bundle branch block (BBB). From January 2006 to December 2014, 93 consecutive patients with sarcoidosis were enrolled (mean age, 55.7 ± 15.7 years; male, 31 %; cardiac involvement, n = 26). TWAaVR showed the greatest sensitivity (39 %) and specificity (92 %) in distinguishing between sarcoidosis patients with and without CI, at a cutoff value of −0.08 mV. The diagnostic value of BBB for cardiac involvement was significantly improved when combined with TWAaVR (sensitivity: 61–94 %, specificity: 97–89 %, area under the curve: 0.79–0.92, p = 0.018). Multivariate logistic regression analysis indicated that TWAaVR and BBB were independent electrocardiography parameters associated with CI. In summary, we observed that sarcoidosis patients exhibiting a high TWAaVR were likely to have CI. Thus, the application of a combination of BBB with TWAaVR may be useful when screening for CI in sarcoidosis patients.